TipRanks
Sarepta Therapeutics (DE:AB3A)
FRANKFURT:AB3A

Compare Sarepta Therapeutics (AB3A) vs. Competitors

6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Sarepta Therapeutics
€13.76
€1.64B
-12.15
-18.59%
4 Buy
9 Hold
4 Sell
Hold
Ultragenyx Pharmaceutical
$26.46
$1.50B
-2.61
-50.74%
10 Buy
10 Hold
0 Sell
Moderate Buy
uniQure
$51.05
$1.63B
-5.81
-56.95%
8 Buy
1 Hold
0 Sell
Strong Buy
Wave Life Sciences
$5.25
$744.84M
-3.47
-46.15%
12 Buy
1 Hold
0 Sell
Strong Buy
Solid Biosciences
$9.89
$734.49M
-3.59
19.34%
10 Buy
0 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$6.02
$1.51B
-10.96
-5.12%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:AB3A
Sarepta Therapeutics
15.52
-4.34
-21.87%
RARE
Ultragenyx Pharmaceutical
15.22
-14.97
-49.59%
QURE
uniQure
23.46
-29.45
-55.66%
WVE
Wave Life Sciences
3.78
-3.44
-47.65%
SLDB
Solid Biosciences
6.85
1.37
25.00%
TSHA
Taysha Gene Therapies
4.63
0.21
4.75%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts